MX2017000927A - Sales de tungsteno (vi) para su uso en el tratamiento de la infertilidad, para favorecer la fertilidad y la reproduccion normal en un mamifero hembra no diabetico, asi como para mejorar la eficacia de las tecnicas de reproduccion asistida. - Google Patents

Sales de tungsteno (vi) para su uso en el tratamiento de la infertilidad, para favorecer la fertilidad y la reproduccion normal en un mamifero hembra no diabetico, asi como para mejorar la eficacia de las tecnicas de reproduccion asistida.

Info

Publication number
MX2017000927A
MX2017000927A MX2017000927A MX2017000927A MX2017000927A MX 2017000927 A MX2017000927 A MX 2017000927A MX 2017000927 A MX2017000927 A MX 2017000927A MX 2017000927 A MX2017000927 A MX 2017000927A MX 2017000927 A MX2017000927 A MX 2017000927A
Authority
MX
Mexico
Prior art keywords
tungsten
effectiveness
female mammal
improving
salts used
Prior art date
Application number
MX2017000927A
Other languages
English (en)
Inventor
Canals Almazán Ignacio
Arbat Bugié Agnés
Original Assignee
Oxolife Sl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxolife Sl filed Critical Oxolife Sl
Publication of MX2017000927A publication Critical patent/MX2017000927A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G41/00—Compounds of tungsten
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G41/00—Compounds of tungsten
    • C01G41/02—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Powder Metallurgy (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Radiation-Therapy Devices (AREA)
  • Electroplating And Plating Baths Therefor (AREA)
  • Inorganic Insulating Materials (AREA)

Abstract

Sales de tungsteno (VI) para su uso en el tratamiento de la infertilidad en un mamífero hembra no diabético, para favorecer la fertilidad y la reproducción normal en un mamífero hembra no diabético, o para aumentar la eficacia de una técnica de reproducción asistida aplicada a un mamífero, así como composiciones que las contienen y métodos de tratamiento con las mismas.
MX2017000927A 2014-07-21 2014-07-21 Sales de tungsteno (vi) para su uso en el tratamiento de la infertilidad, para favorecer la fertilidad y la reproduccion normal en un mamifero hembra no diabetico, asi como para mejorar la eficacia de las tecnicas de reproduccion asistida. MX2017000927A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/ES2014/070586 WO2016012632A1 (es) 2014-07-21 2014-07-21 Sales de tungsteno (vi) para su uso en el tratamiento de la infertilidad, para favorecer la fertilidad y la reproducción normal en un mamífero hembra no diabético, así como para mejorar la eficacia de las técnicas de reproducción asistida

Publications (1)

Publication Number Publication Date
MX2017000927A true MX2017000927A (es) 2017-05-01

Family

ID=55162540

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017000927A MX2017000927A (es) 2014-07-21 2014-07-21 Sales de tungsteno (vi) para su uso en el tratamiento de la infertilidad, para favorecer la fertilidad y la reproduccion normal en un mamifero hembra no diabetico, asi como para mejorar la eficacia de las tecnicas de reproduccion asistida.

Country Status (27)

Country Link
US (1) US10376540B2 (es)
EP (1) EP3173382B1 (es)
JP (1) JP6534439B2 (es)
KR (1) KR102282865B1 (es)
CN (1) CN106715332B (es)
AR (1) AR101252A1 (es)
AU (1) AU2014401750B2 (es)
BR (1) BR112017001287A2 (es)
CA (1) CA2955914C (es)
DK (1) DK3173382T3 (es)
ES (1) ES2940465T3 (es)
FI (1) FI3173382T3 (es)
HR (1) HRP20230223T1 (es)
HU (1) HUE061726T2 (es)
IL (1) IL250212B (es)
LT (1) LT3173382T (es)
MX (1) MX2017000927A (es)
PL (1) PL3173382T3 (es)
PT (1) PT3173382T (es)
RS (1) RS64025B1 (es)
RU (1) RU2679623C2 (es)
SG (1) SG11201700485VA (es)
SI (1) SI3173382T1 (es)
TW (1) TWI709407B (es)
UY (1) UY36222A (es)
WO (1) WO2016012632A1 (es)
ZA (1) ZA201701241B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4368577A1 (en) 2022-11-08 2024-05-15 Oxolife, S.L. Process for the preparation of tungsten (vi) salt hydrates

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2245374B1 (es) * 1973-07-27 1977-02-25 Anvar
US4328134A (en) * 1980-05-06 1982-05-04 Schally Andrew Victor Anorexigenic peptides
ES2108642B1 (es) * 1995-07-26 1998-08-16 Quimica Farm Bayer Sa Composiciones de tungsteno (vi) para el tratamiento oral de la diabetes mellitus.
RU2202314C2 (ru) * 2001-04-11 2003-04-20 Алексей Иванович Ступко Способ подготовки пациентки к искусственному оплодотворению
ES2187276B1 (es) * 2001-05-16 2004-08-01 Quimica Farmaceutica Bayer,S.A. Composiciones orales para el tratamiento de humanos obesos y no diabeticos.
AU2002368261A1 (en) * 2002-10-02 2004-04-23 Yeda Research And Development Co. Ltd. Long-acting gonadotropin-releasing hormone analogs and methods of use thereof
EP1523985B1 (en) * 2003-10-17 2010-03-10 Oy Neurofood Ab Non-radioactive strontium agent for treating cancer
CN102321584B (zh) * 2003-12-31 2014-01-08 宾夕法尼亚州研究基金会 预测并克服对卵巢癌化疗的抗性的方法及预测结肠癌发生的方法
CA2614210A1 (en) * 2005-07-05 2007-01-11 Adelaide Fertility Centre Pty Ltd Methods and compositions for improving pregnancy outcome
JP2009502891A (ja) * 2005-07-29 2009-01-29 ユニベルシダード デ バルセロナ 神経変性疾患、特にアルツハイマー病及び統合失調症の治療のためのタングステン酸塩（ｖｉ）を含有してなる製薬的組成物
US20060100154A1 (en) * 2005-10-13 2006-05-11 Yeda Research And Development Co Long-acting gonadotropin-releasing hormone analogs and methods of use thereof
PL2086642T3 (pl) * 2006-10-18 2015-02-27 Periness Ltd DNaza do leczenia męskiej subpłodności
ES2478790B1 (es) * 2013-01-22 2015-05-06 Oxolife, S. L. Uso de sales de tungsteno (VI) para el tratamiento de la infertilidad femenina en mamíferos no diabéticos
ES2551828B1 (es) * 2014-05-21 2016-09-12 Oxolife S.L. Composiciones alimentarias que comprenden sales de tungsteno (VI)

Also Published As

Publication number Publication date
HRP20230223T1 (hr) 2023-04-14
TWI709407B (zh) 2020-11-11
EP3173382A1 (en) 2017-05-31
HUE061726T2 (hu) 2023-08-28
CN106715332B (zh) 2019-01-29
LT3173382T (lt) 2023-03-27
AU2014401750A1 (en) 2017-02-09
AR101252A1 (es) 2016-12-07
PL3173382T3 (pl) 2023-05-08
SI3173382T1 (sl) 2023-04-28
EP3173382B1 (en) 2023-01-04
PT3173382T (pt) 2023-03-10
JP2017523170A (ja) 2017-08-17
CA2955914A1 (en) 2016-01-28
JP6534439B2 (ja) 2019-06-26
ZA201701241B (en) 2022-05-25
FI3173382T3 (fi) 2023-03-25
CN106715332A (zh) 2017-05-24
RU2679623C2 (ru) 2019-02-12
WO2016012632A1 (es) 2016-01-28
RU2017105257A3 (es) 2018-08-21
US10376540B2 (en) 2019-08-13
DK3173382T3 (da) 2023-03-13
AU2014401750B2 (en) 2019-10-24
IL250212A0 (en) 2017-03-30
KR102282865B1 (ko) 2021-07-28
SG11201700485VA (en) 2017-02-27
TW201618796A (zh) 2016-06-01
UY36222A (es) 2016-01-29
WO2016012632A9 (es) 2017-05-18
CA2955914C (en) 2022-09-06
BR112017001287A2 (pt) 2018-01-30
ES2940465T3 (es) 2023-05-08
NZ728467A (en) 2021-04-30
RU2017105257A (ru) 2018-08-21
US20170173074A1 (en) 2017-06-22
RS64025B1 (sr) 2023-03-31
KR20170029627A (ko) 2017-03-15
EP3173382A4 (en) 2018-03-21
IL250212B (en) 2020-06-30

Similar Documents

Publication Publication Date Title
MX2021006734A (es) Metodo para tratar el cancer.
CR20190478A (es) Inhibidores de pd-1/pd-l1
EP4218804A3 (en) Use of myostatin inhibitors and combination therapies
MX2021002406A (es) Composiciones farmaceuticas que comprenden un inhibidor de il-4r para usarse en el tratamiento de la esofagitis eosinofilica.
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
EP4252851A3 (en) Ezh2 inhibitors for treating lymphoma
GB2541571A (en) Pharmaceutical compositions
MX2018002344A (es) Metodo para tratar el cancer.
PH12016500270A1 (en) Combination of a mek inhibitor and an erk inhibitor for use in treatment of hyperproliferative diseases
CO2017004784A2 (es) Isómeros de ácido-1-[(3-cloro-2-fluoro-fenil)metil]-4-[[3-fluoro-6-[(5-metil-1h-pirazol-3-il)amino]-2-piridil]metil]-2-metil-piperidin-4-carboxílico como inhibidores de la cinasa aurora a
MX2022012386A (es) Compuestos inhibidores de metaloenzimas.
AU2015267099A8 (en) Use of eribulin in the treatment of cancer
NZ722600A (en) Methods of treating mild brain injury
MX2017011018A (es) Inhibicion de la actividad de olig2.
MX2016009655A (es) Metodos novedosos para el tratamiento del cancer.
ZA201901367B (en) Inhibition of olig2 activity
TW201613569A (en) Composition consisting of kukoamine A and/or kukoamine B and method of using thereof
MX2023003924A (es) Metodos de administracion de tratamiento antifibrotico.
NZ724799A (en) Compositions and methods for the treatment or prevention of neurodegenerative disorders
MX2017000927A (es) Sales de tungsteno (vi) para su uso en el tratamiento de la infertilidad, para favorecer la fertilidad y la reproduccion normal en un mamifero hembra no diabetico, asi como para mejorar la eficacia de las tecnicas de reproduccion asistida.
NZ747201A (en) (+)-azasetron for use in the treatment of ear disorders
MA39718A (fr) Compositions et méthodes d'utilisation de celles-ci